Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
出版年份 2017 全文链接
标题
Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-08-21
DOI
10.1038/s41598-017-09528-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neuroinflammation in Alzheimer's Disease: Are NSAIDs and Selective COX-2 Inhibitors the Next Line of Therapy?
- (2017) Catherine H. Trepanier et al. JOURNAL OF ALZHEIMERS DISEASE
- α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson’s disease patients
- (2017) Birger Victor Dieriks et al. Scientific Reports
- Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study
- (2016) Minju Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
- (2016) Shih-Heng Chen et al. CURRENT OPINION IN PHARMACOLOGY
- Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus
- (2016) Yifeng Du et al. Expert Review of Neurotherapeutics
- Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease
- (2016) Suraj S. Pradhan et al. Journal of Neuroimmune Pharmacology
- Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside
- (2016) Avijit Dey et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus
- (2016) Yifeng Du et al. Expert Review of Neurotherapeutics
- Prostaglandin E2 Receptor Subtype 2 Regulation of Scavenger Receptor CD36 Modulates Microglial Aβ42 Phagocytosis
- (2015) Xianwu Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Candidate Drug Targets for Prevention or Modification of Epilepsy
- (2015) Nicholas H. Varvel et al. Annual Review of Pharmacology and Toxicology
- Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus
- (2015) Jianxiong Jiang et al. NEUROBIOLOGY OF DISEASE
- Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice
- (2015) D. Lecca et al. NEUROSCIENCE
- Development of second generation EP2 antagonists with high selectivity
- (2014) Thota Ganesh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prostaglandin signaling suppresses beneficial microglial function in Alzheimer’s disease models
- (2014) Jenny U. Johansson et al. JOURNAL OF CLINICAL INVESTIGATION
- Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
- (2014) Thota Ganesh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling
- (2014) N. S. Woodling et al. JOURNAL OF NEUROSCIENCE
- Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells
- (2014) Seung-Hwan Kwon et al. NEUROCHEMISTRY INTERNATIONAL
- Cyclooxygenase-2 in epilepsy
- (2013) Asheebo Rojas et al. EPILEPSIA
- EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia
- (2013) Yi Quan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia
- (2013) J. U. Johansson et al. JOURNAL OF NEUROSCIENCE
- Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation
- (2013) Jianxiong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
- (2013) Jianxiong Jiang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery and Characterization of Carbamothioylacrylamides As EP2 Selective Antagonists
- (2013) Thota Ganesh et al. ACS Medicinal Chemistry Letters
- A Guide to Neurotoxic Animal Models of Parkinson's Disease
- (2013) K. Tieu Cold Spring Harbor Perspectives in Medicine
- COX-2 in the neurodegenerative process of Parkinson's disease
- (2012) Peter Teismann BIOFACTORS
- Cellular models to investigate biochemical pathways in Parkinson’s disease
- (2012) Tiziana Alberio et al. FEBS Journal
- Effect of quercetin and its glucuronide metabolite upon 6-hydorxydopamine-induced oxidative damage in Neuro-2a cells
- (2012) Rie Mukai et al. FREE RADICAL RESEARCH
- Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer
- (2012) Raynoo Thanan et al. MEDIATORS OF INFLAMMATION
- Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2
- (2012) J. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats
- (2012) Eun Young Lee et al. TOXICOLOGY LETTERS
- Prostaglandin E2 and Pain—An Update
- (2011) Atsufumi Kawabata BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
- (2011) Huizhi Du et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostanoid Receptors
- (2011) Takako Hirata et al. CHEMICAL REVIEWS
- MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress
- (2011) Ya-Ching Hsieh et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
- (2010) Tilo Grosser et al. Annual Review of Medicine
- Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma
- (2010) Paola Maroni et al. BREAST CANCER RESEARCH AND TREATMENT
- The Prostaglandin E2 E-Prostanoid 4 Receptor Exerts Anti-Inflammatory Effects in Brain Innate Immunity
- (2010) J. Shi et al. JOURNAL OF IMMUNOLOGY
- COX-2's new role in inflammation
- (2010) Chu Chen Nature Chemical Biology
- Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
- (2010) J. J. Gagne et al. NEUROLOGY
- Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
- (2010) J. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differentiation of mouse Neuro 2A cells into dopamine neurons
- (2009) Roger G. Tremblay et al. JOURNAL OF NEUROSCIENCE METHODS
- Emerging roles of PGE2 receptors in models of neurological disease
- (2009) Katrin Andreasson PROSTAGLANDINS & OTHER LIPID MEDIATORS
- The prostaglandin E2EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
- (2008) Xibin Liang et al. ANNALS OF NEUROLOGY
- Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
- (2008) Jian Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxidative and Inflammatory Pathways in Parkinson’s Disease
- (2008) Rebecca L. Miller et al. NEUROCHEMICAL RESEARCH
- Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress
- (2008) Emilce Carrasco et al. NEUROSCIENCE LETTERS
- GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist
- (2006) Richard J Wilson et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started